Literature DB >> 6883303

Direct bone resorbing activity of murine myeloma cells.

D F McDonald, B H Schofield, E M Prezioso, V L Adams, C A Frondoza, S M Trivedi, C Craig, R L Humphrey.   

Abstract

The cellular mechanism(s) responsible for tumor-associated bone resorption in multiple myeloma remain uncertain. Both in vivo and in vitro evidence is presented for the direct resorption of bone by mouse plasmacytomas. Morphological examination of autopsy specimens from tumor-bearing mice revealed in vivo erosion of bony surfaces at sites of tumor cell-bone matrix apposition. No osteoclastic bone resorptive activity was evident. Using a 45Ca-labelled, devitalized bone explant assay system, mouse myeloma cells caused the release of isotope at levels from 200-300% above control values. Control cells such as normal spleen lymphocytes and liver cells did not resorb bone. Demonstration of the ability of myeloma cells to independently destroy bone is important to the understanding of the causes of and development of chemotherapeutic approaches to myelomatous bone resorption.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6883303     DOI: 10.1016/0304-3835(83)90145-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities.

Authors:  G Shay; L Hazlehurst; C C Lynch
Journal:  J Mol Med (Berl)       Date:  2015-10-01       Impact factor: 4.599

2.  A gene expression-based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment.

Authors:  Ping Wu; Brian A Walker; Daniel Brewer; Walter M Gregory; John Ashcroft; Fiona M Ross; Graham H Jackson; Anthony J Child; Faith E Davies; Gareth J Morgan
Journal:  Clin Cancer Res       Date:  2011-08-19       Impact factor: 12.531

3.  A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.

Authors:  Kimberly Noonan; Luigi Marchionni; Judy Anderson; Drew Pardoll; G David Roodman; Ivan Borrello
Journal:  Blood       Date:  2010-07-27       Impact factor: 22.113

4.  Resorbing bone stimulates tumor cell growth. A role for the host microenvironment in bone metastasis.

Authors:  W J Manishen; K Sivananthan; F W Orr
Journal:  Am J Pathol       Date:  1986-04       Impact factor: 4.307

Review 5.  Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma.

Authors:  Anna Mansour; Abdelilah Wakkach; Claudine Blin-Wakkach
Journal:  Front Immunol       Date:  2017-08-11       Impact factor: 7.561

Review 6.  Myeloma bone disease.

Authors:  Ralph D Sanderson; Joshua Epstein
Journal:  J Bone Miner Res       Date:  2009-11       Impact factor: 6.741

Review 7.  Osteosarcoma and Metastasis Associated Bone Degradation-A Tale of Osteoclast and Malignant Cell Cooperativity.

Authors:  Kirstine Sandal Nørregaard; Henrik Jessen Jürgensen; Henrik Gårdsvoll; Lars Henning Engelholm; Niels Behrendt; Kent Søe
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.